Drug intelligence / Profile preview

demineralized dentin allograft

Development stage
Phase 2
Lead developer
Cairo University
Administration
Topical
01

Overview

Demineralized dentin allograft (DDA) is a regenerative biomaterial derived from processed human donor teeth, primarily utilized in dental and maxillofacial surgery for bone augmentation and alveolar ridge preservation. Biochemically similar to bone, dentin consists of an inorganic mineral phase and an organic matrix rich in Type I collagen and sequestered bioactive molecules, including bone morphogenetic proteins (BMPs) and transforming growth factor-beta (TGF-β). The demineralization process removes the hydroxyapatite component to expose these growth factors, making them bioavailable to the recipient site. DDA functions through both osteoconduction, providing a structural scaffold for host bone growth, and osteoinduction, where released proteins signal the differentiation of mesenchymal stem cells into osteoblasts. It offers a sustainable and scalable alternative to autogenous bone grafts, eliminating donor-site morbidity while maintaining high biocompatibility and effectiveness in maintaining ridge volume post-extraction.

Other names
DDAallogenic dentin graftdemineralized allogenic dentin matrixallogeneic demineralized dentin matrix
02

Targets

BMPR (Bone morphogenetic protein receptor)TGFBR (TGF-beta receptor)

Beyond the preview

Go deeper on demineralized dentin allograft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on demineralized dentin allograft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call